[Which patient with chronic atrial fibrillation suits well for device closure of the left atrial appendage?]

P Wagdi1, M Ritter, F Salzer

  • 1HerzZentrum Hirslanden, Zürich.

Praxis
|March 18, 2011
PubMed

Insights

Atrial fibrillation, a common condition in older adults, significantly increases stroke risk. Left atrial appendage closure offers a promising alternative to oral anticoagulation for stroke prevention.

Area of Science:

  • Cardiology
  • Neurology
  • Geriatrics

Background:

  • Atrial fibrillation (AF) impacts approximately 3% of individuals over 65.
  • AF is linked to a substantial proportion (15-20%) of all cerebrovascular insults.
  • Chronic AF patients have a 30% risk of experiencing at least one cerebrovascular accident.

Observation:

  • A CHADS2 score of 3 or higher reliably predicts future cerebrovascular events in chronic AF patients.
  • Oral anticoagulation is the primary treatment for preventing thromboembolic complications in AF.

Findings:

  • Percutaneous left atrial appendage closure is an emerging treatment strategy.
  • This closure method shows promise as an alternative for patients intolerant to oral anticoagulation.

Implications:

  • Left atrial appendage closure may reduce stroke risk in specific patient populations.
  • This intervention offers a viable option for elderly patients with AF who cannot tolerate oral anticoagulants.
  • Further research into left atrial appendage closure is warranted to establish its long-term efficacy and safety.